OPRX Valuation

OptimizeRx Corp

Add to Watchlist

Advanced Chart

19.090

+0.89(4.890%)1D

Overview
Forecast
Valuation
Earnings

OPRX Relative Valuation

OPRX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OPRX is overvalued; if below, it's undervalued.

Historical Valuation

OptimizeRx Corp (OPRX) is now in the Fair zone, suggesting that its current forward PE ratio of 36.44 is considered Fairly compared with the five-year average of 62.31. The fair price of OptimizeRx Corp (OPRX) is between 14.94 to 45.99 according to relative valuation methord.

Relative Value

Fair Zone

14.94-45.99

Current Price：19.09

Fair

36.44

Trailing

Forward

24.44

EV/EBITDA

OptimizeRx Corp. (OPRX) has a current EV/EBITDA of 24.44. The 5-year average EV/EBITDA is 60.35. The thresholds are as follows: Strongly Undervalued below -91.97, Undervalued between -91.97 and -15.81, Fairly Valued between 136.51 and -15.81, Overvalued between 136.51 and 212.67, and Strongly Overvalued above 212.67. The current Forward EV/EBITDA of 24.44 falls within the Historic Trend Line -Fairly Valued range.

148.77

EV/EBIT

OptimizeRx Corp. (OPRX) has a current EV/EBIT of 148.77. The 5-year average EV/EBIT is 142.76. The thresholds are as follows: Strongly Undervalued below -588.64, Undervalued between -588.64 and -222.94, Fairly Valued between 508.46 and -222.94, Overvalued between 508.46 and 874.15, and Strongly Overvalued above 874.15. The current Forward EV/EBIT of 148.77 falls within the Historic Trend Line -Fairly Valued range.

3.13

OptimizeRx Corp. (OPRX) has a current PS of 3.13. The 5-year average PS is 6.17. The thresholds are as follows: Strongly Undervalued below -4.75, Undervalued between -4.75 and 0.71, Fairly Valued between 11.63 and 0.71, Overvalued between 11.63 and 17.10, and Strongly Overvalued above 17.10. The current Forward PS of 3.13 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

OptimizeRx Corp. (OPRX) has a current P/OCF of 0.00. The 5-year average P/OCF is 56.13. The thresholds are as follows: Strongly Undervalued below -164.69, Undervalued between -164.69 and -54.28, Fairly Valued between 166.55 and -54.28, Overvalued between 166.55 and 276.96, and Strongly Overvalued above 276.96. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

OptimizeRx Corp. (OPRX) has a current P/FCF of 0.00. The 5-year average P/FCF is 77.67. The thresholds are as follows: Strongly Undervalued below -156.61, Undervalued between -156.61 and -39.47, Fairly Valued between 194.81 and -39.47, Overvalued between 194.81 and 311.94, and Strongly Overvalued above 311.94. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

OptimizeRx Corp (OPRX) has a current Price-to-Book (P/B) ratio of 2.97. Compared to its 3-year average P/B ratio of 1.71 , the current P/B ratio is approximately 73.91% higher. Relative to its 5-year average P/B ratio of 4.16, the current P/B ratio is about -28.54% higher. OptimizeRx Corp (OPRX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 0.80%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 0.41% , the current FCF yield is about -100.00% lower.

2.97

P/B

Median3y

1.71

Median5y

4.16

3.06

FCF Yield

Median3y

0.80

Median5y

0.41

Competitors Valuation Multiple

The average P/S ratio for OPRX's competitors is 0.00, providing a benchmark for relative valuation. OptimizeRx Corp Corp (OPRX) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 55.19%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Lesaka Technologies Inc

GCL Global Holdings Ltd

Performance Decomposition

Market capitalization of OPRX increased by 147.28% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -11.18 to -35.42.

The secondary factor is the Revenue Growth, contributed 55.19%to the performance.

Overall, the performance of OPRX in the past 1 year is driven by P/E Change. Which is more unsustainable.

55.19%

18.81M → 29.20M

Revenue Growth

-124.64%

-21.31 → 5.25

Margin Expansion

216.73%

-11.18 → -35.42

P/E Change

147.28%